These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17036580)
1. An unavoidable and unmistakable link. Rossi MS N Y State Dent J; 2006; 72(5):6-8. PubMed ID: 17036580 [No Abstract] [Full Text] [Related]
2. Bisphosphonate-induced osteonecrosis of the jaws: a challenge, a responsibility, and an opportunity. Marx RE Int J Periodontics Restorative Dent; 2008 Feb; 28(1):5-6. PubMed ID: 18351197 [No Abstract] [Full Text] [Related]
3. Low-down on link between bone-builders and jaw damage. Johns Hopkins Med Lett Health After 50; 2006 Sep; 18(7):1-2. PubMed ID: 17120363 [No Abstract] [Full Text] [Related]
15. Bisphosphonate use and health history questionnaire. Dao V; Kraut RA N Y State Dent J; 2008 Nov; 74(6):20-2. PubMed ID: 19195232 [TBL] [Abstract][Full Text] [Related]
16. Standard protocols. Kini G Br Dent J; 2007 Oct; 203(8):440. PubMed ID: 17965662 [No Abstract] [Full Text] [Related]
17. Do Fosamax-type drugs increase the risk of osteonecrosis of the jaw for patients receiving dental implants? Wynn RL Gen Dent; 2008; 56(5):410-1. PubMed ID: 18683394 [No Abstract] [Full Text] [Related]
18. Osteonecrosis of the jaw. Sykes DL Dent Today; 2007 Feb; 26(2):16. PubMed ID: 17348272 [No Abstract] [Full Text] [Related]
19. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient. Ruggiero SL; Carlson ER; Assael LA J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808 [No Abstract] [Full Text] [Related]
20. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association? Aragon-Ching JB; Dahut WL Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325 [No Abstract] [Full Text] [Related] [Next] [New Search]